Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-500-3 | CAS number: 161074-67-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1998-02-24 to 1998-03-10
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD guideline, GL study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- Glutens, hydrolyzates, reaction products with lauroyl chloride, sodium salts
- EC Number:
- 500-500-3
- EC Name:
- Glutens, hydrolyzates, reaction products with lauroyl chloride, sodium salts
- Cas Number:
- 161074-67-5
- Molecular formula:
- Not applicable
- IUPAC Name:
- Acylation product between lauroyl chloride and amino acids
- Test material form:
- other: liquid
- Details on test material:
- • Identification, reference: PROTEOL OAT - Batch 97 255 001
• Appearance : yellowish liquid
• Purity:28,7% dry matter
• Quantity received, packaging : 250 ml, plastic bottle
• Date ofreceipt : February 09, 1998
• Analytical sheet : reported in appendix
• Storage : at room temperature, away from the light
Constituent 1
- Specific details on test material used for the study:
- • Identification, reference: PROTEOL OAT - Batch 97 255 001
• Appearance : yellowish liquid
• Purity:28,7% dry matter
• Quantity received, packaging : 250 ml, plastic bottle
• Date ofreceipt : February 09, 1998
• Analytical sheet : reported in appendix
• Storage : at room temperature, away from the light
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Species, strain, supplier : Albino Rat, Sprague Dawley 0M, IFFA-CREDO (69210 - L’ARBRESLE, FRANCE).
Reason for species selection : the Rat is the animal chosen by the regulatory authorities to evaluate the safety of drugs and chemicals
- Number and sex: 10 animals: 5 males and 5 females
- Age, weight : about 6 weeks, weight between 189 g and 208 g (males) and 172 g and 187 g (females) at the beginning of the study.
- Acclimatization : at least 5 days
- Housing, diet: 5 animals by sex in polypropylene cages (310 x 465 x 190) in accordance with the requirements of the 86/609/EEC guideline. Complete pelleted rat maintenance diet UAR A04-10 (91360 - EPINAY SUR ORGE, FRANCE).
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- Animais have been fasted prior to substance administration by withholding food overnight.
They received by gavage, according to the bodyweight, the product diluted with distilled water (Meram batch 62421) at the single dose of 2000 mg/kg under a constant volume of 5 ml/kg.
The administered preparation was kept up under magnetic stirring during the treatments. - Doses:
- 2000 mg / kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- Observations
The animals were observed daily for 14 days after the treatment.
Clinical observations:
-A clinical observation was carried out at least once a day in order to evaluate the general appearance , the behaviour and vegetative functions of the animals. An individual clinical observation was realized one hour after treatment. The continuous observations during the five following hours were renewed each following day.
-Body weights were taken just prior to the test material administration (D1) and again on days 4,8 and 15.
-Macroscopic examinations:
.At the termination of the 14 observation days, the rats were sacrified after barbituric anaesthesia, then autopsied. All abnormalities were recorded. - Statistics:
- no statistic
Results and discussion
- Preliminary study:
- No preliminary study
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred.
- Clinical signs:
- other: No modification in the aspect, behaviour or vegetative functions was observed in the animals, 1 hour after the treatment or during the 5 following hours, excepted a slight piloerection visible during the first hour following the ingestion of the product.
- Gross pathology:
- The gross necropsy of the animaIs 14 days after the treatment did not show any visible organic or tissular lesions leading us to suspect a possible systemic toxicity ofthe product.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the experimental conditions adopted, the oral LD0 of the test material PROTEOL OAT - Batch 97 255 001 in male and female Rat is higher than 2000 mg/kg.
According to the 67/548/EEC directive, the test preparation is unclassified if swallowed - Executive summary:
the single oral administration of the preparation PROTEOL OAT-Batch 97 255 001 in the male and female Rat at the dose of 2000 mg/kg:
- Did not induce any death
- Had no significant toxic effect on the animals' behaviour or vegetative functions,
- Did not modify their weight growth,
- Did not cause any gross lesion visible at autopsy.
Under the experimental conditions adopted, oral LD50 of the test preparation is higher than 2000 mg/kg in the rat.
According to the 67/548/EEC directive, the test preparation is unclassified if swallowed
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.